These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 817772)

  • 21. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H; Eiberg B; Helin P; Svejgaard A
    Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR antigens in gold-induced neutropenia.
    Aaron S; Davis P; Bertouch J
    Arthritis Rheum; 1986 Dec; 29(12):1515-7. PubMed ID: 3099800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.
    Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT
    Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)].
    Slobodina GA
    Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the response of the leukopenia of rheumatoid arthritis to gold salt therapy.
    Mastaglia GL; Owen ET
    J Rheumatol; 1981; 8(4):658-60. PubMed ID: 6795350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gold-induced thrombocytopenia: response to vincristine?
    Ball GV
    Arthritis Rheum; 1977; 20(6):1288-9. PubMed ID: 409415
    [No Abstract]   [Full Text] [Related]  

  • 27. Chrysotherapy and thrombocytopenia.
    Madhok R; Pullar T; Capell HA; Dawood F; Sturrock RD; Dick HM
    Ann Rheum Dis; 1985 Sep; 44(9):589-91. PubMed ID: 3929704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary damage associated with sodium aurothiomalate therapy.
    Gould PW; McCormack PL; Palmer DG
    J Rheumatol; 1977; 4(3):252-60. PubMed ID: 411928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold toxicity and peritoneal dialysis.
    Combs RJ; Dentino MM; Lehrman L; Szwed JJ
    Arthritis Rheum; 1976; 19(5):936-8. PubMed ID: 822853
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombocytopenia associated with gold therapy. Observations on the mechanism of platelet destruction.
    Levin HA; McMillan R; Tavassoli M; Longmire RL; Yelenosky R; Sacks PV
    Am J Med; 1975 Aug; 59(2):274-80. PubMed ID: 808125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine-induced blood dyscrasias in Saudi Arab patients.
    Abanmy NO; Al-Jaloud A; Al-Jabr A; Al-Ruwaisan R; Al-Saeed W; Fatani S
    Int J Clin Pharm; 2014 Aug; 36(4):815-20. PubMed ID: 24917217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone marrow aplasia and gold salts. Review of the literature apropos of 2 cases].
    Pérez MC; Gómez Casares MT; Mataix R; Campo C; Jiménez S; Malcorra JJ
    Rev Clin Esp; 1994 Jul; 194(7):540-2. PubMed ID: 7938822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis.
    Bretza J; Wells I; Novey HS
    Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold-induced immune thrombocytopenia in the dog.
    Bloom JC; Blackmer SA; Bugelski PJ; Sowinski JM; Saunders LZ
    Vet Pathol; 1985 Sep; 22(5):492-9. PubMed ID: 3931338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary gold toxicity.
    Morley TF; Komansky HJ; Adelizzi RA; Giudice JC
    Eur J Respir Dis; 1984 Nov; 65(8):627-32. PubMed ID: 6440806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.